These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35156616)

  • 21. A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics.
    Ferrari R; Ford I; Fox K; Marzilli M; Tendera M; Widimský P; Challeton JP; Danchin N
    Am Heart J; 2019 Apr; 210():98-107. PubMed ID: 30771737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).
    Zhang Z; Jones P; Weintraub WS; Mancini GBJ; Sedlis S; Maron DJ; Teo K; Hartigan P; Kostuk W; Berman D; Boden WE; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e003971. PubMed ID: 29752388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of Xinnaoning capsule in treating chronic stable angina (qi stagnation and blood stasis syndrome): Study protocol for a multicenter, randomized, double-blind, placebo-controlled trial.
    Zhao JN; Zhang Y; Lan X; Chen Y; Li J; Zhang P; Wu LQ; Jia ST; Liu Y; Xu FQ
    Medicine (Baltimore); 2019 Aug; 98(31):e16539. PubMed ID: 31374015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of Suxiao Jiuxin Pill in the treatment of stable angina (Qi stagnation and blood stasis syndrome): study protocol of a randomized, double-blind, placebo-controlled, multi-center clinical trial.
    Ruan X; Li Y; Sun Y; Jia M; Xu X; Huo L; Song W; Yao Y; Wang X
    Trials; 2021 Jul; 22(1):466. PubMed ID: 34281600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of Danshen extract on lipoprotein-associated phospholipase A
    Chen AD; Wang CL; Qin Y; Tian L; Chen LB; Yuan XM; Ma LX; Wang YF; Sun JR; Wang HS; Dai N;
    Trials; 2017 Dec; 18(1):606. PubMed ID: 29262859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-of-1 Trial of Angina Verification Before Percutaneous Coronary Intervention.
    Rajkumar CA; Foley MJ; Ahmed-Jushuf F; Simader FA; Mohsin M; Ganesananthan S; Nowbar AN; Chotai S; Sen S; Petraco R; Nijjer SS; Sehmi J; Ruparelia N; Dungu JN; Kabir A; Tang K; Gamma R; Davies JR; Kotecha T; Cole GD; Howard JP; Keeble TR; Clesham G; O'Kane PD; Harrell FE; Francis DP; Shun-Shin MJ; Al-Lamee RK
    J Am Coll Cardiol; 2024 Jul; 84(1):1-12. PubMed ID: 38752902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial.
    Alexander KP; Weisz G; Prather K; James S; Mark DB; Anstrom KJ; Davidson-Ray L; Witkowski A; Mulkay AJ; Osmukhina A; Farzaneh-Far R; Ben-Yehuda O; Stone GW; Ohman EM
    Circulation; 2016 Jan; 133(1):39-47. PubMed ID: 26555329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ORBITA trial: A point of view.
    Oliveira VD; Giugni FR; Martins EB; Azevedo DFC; Lima EG; Serrano Júnior CV
    Rev Assoc Med Bras (1992); 2018 Feb; 64(2):100-103. PubMed ID: 29641663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of oral Guanxinshutong capsules in patients with stable angina pectoris in China: a prospective, multicenter, double-blind, placebo-controlled, randomized clinical trial.
    Li Y; Zhang L; Lv S; Wang X; Zhang J; Tian X; Zhang Y; Chen B; Liu D; Yang J; Dong P; Xu Y; Song Y; Shi J; Li L; Wang X; Han Y
    BMC Complement Altern Med; 2019 Dec; 19(1):363. PubMed ID: 31829173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inorganic Nitrate in Angina Study: A Randomized Double-Blind Placebo-Controlled Trial.
    Schwarz K; Singh S; Parasuraman SK; Rudd A; Shepstone L; Feelisch M; Minnion M; Ahmad S; Madhani M; Horowitz J; Dawson DK; Frenneaux MP
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28887315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial.
    Brown LK; Freemantle N; Breuer J; Dehbi HM; Chowdhury K; Jones G; Ikeji F; Ndoutoumou A; Santhirakumar K; Longley N; Checkley AM; Standing JF; Lowe DM
    Trials; 2021 Mar; 22(1):193. PubMed ID: 33685502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rates of Elective Percutaneous Coronary Intervention in England and Wales: Impact of COURAGE and ORBITA Trials.
    Rashid M; Stevens C; Wijeysundera HC; Curzen N; Khoo CW; Mohamed MO; Aktaa S; Wu J; Ludman PF; Mamas MA
    J Am Heart Assoc; 2022 Sep; 11(18):e025426. PubMed ID: 36102261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous coronary intervention for the management of stable ischemic heart disease.
    Liu S; Tsang M; Abdel-Qadir H; Yanagawa B; Bagai A
    Curr Opin Cardiol; 2019 Sep; 34(5):557-563. PubMed ID: 31246588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Danhong injection in the treatment of chronic stable angina: study protocol for a randomized controlled trial.
    Wang PQ; Li DD; Dong W; Liu J; Yu YN; Shen CT; Chen QG; Chen BW; Chen YD; Wang Z
    Trials; 2015 Oct; 16():474. PubMed ID: 26489511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ORBITA: What Goes Around, Comes Around… Or Does It?
    Jackson M; Zaman A
    Interv Cardiol; 2018 Sep; 13(3):135-136. PubMed ID: 30443270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In adults with stable angina, PCI vs. a placebo procedure reduced angina symptoms at 12 wk.
    Bavishi C
    Ann Intern Med; 2024 Mar; 177(3):JC28. PubMed ID: 38437691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antianginal therapy before percutaneous coronary intervention.
    Borden WB; Spertus JA; Mushlin AI; Roe MT; McCoy LA; Redberg RF
    Circ Cardiovasc Interv; 2013 Aug; 6(4):436-43. PubMed ID: 23922143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guanxinjing capsule in the treatment of chronic stable angina: study protocol for a randomized controlled trial.
    Tian Y; Zhang J; Zhao Y; Mao J; Zhu L; Gao R; Wang X; Zhu M; Ma L; Zhao M; Zheng W
    Trials; 2018 Oct; 19(1):577. PubMed ID: 30342551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.